SUBSCRIBE
SUBSCRIBE
News   Business

Sterling to Buy Canadian Drug Plant

December 3, 2009 | 
1 min read
Bookmark and Share

in-pharmatechnologist.com -- Australia’s Sterling Products plans to buy a 4,310 sqm pharmaceutical manufacturing plant from a Canadian drugmaker that has fallen victim to the global economic crisis.
Real estate Asia Australia
MORE ON THIS TOPIC
Pictured: Roche tower in Basel, Switzerland
Manufacturing
Roche Seeks Antibiotic Partner as Rising Manufacturing Costs Drive Supply Rethink
February 24, 2026
 · 
1 min read
 · 
Nick Paul Taylor
Business people shaking hand in China.
GLP-1
Pfizer Builds Global GLP-1 Strategy With up to $495M Sciwind Deal
February 24, 2026
 · 
2 min read
 · 
Tristan Manalac
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO tracker
Generate’s IPO Could Reach $425M, Largest Raise Yet
February 24, 2026
 · 
5 min read
 · 
Tristan Manalac
Manual worker with protective work gloves holding a yellow safety helmet on a yellow and orange background with copy space and reflections. Concept of workplace security.
Manufacturing
AbbVie Backs Obesity Push With $380M API Production Expansion Project in Illinois
February 24, 2026
 · 
2 min read
 · 
Nick Paul Taylor